OXYPHENONIUM BROMIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for oxyphenonium bromide and what is the scope of freedom to operate?
Oxyphenonium bromide
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for OXYPHENONIUM BROMIDE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 46 |
| Patent Applications: | 1,330 |
| DailyMed Link: | OXYPHENONIUM BROMIDE at DailyMed |
Medical Subject Heading (MeSH) Categories for OXYPHENONIUM BROMIDE
Anatomical Therapeutic Chemical (ATC) Classes for OXYPHENONIUM BROMIDE
US Patents and Regulatory Information for OXYPHENONIUM BROMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | ANTRENYL | oxyphenonium bromide | TABLET;ORAL | 008492-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
